Akebia Therapeutics, Inc. (AKBA): Form 8-K filed 2026-10-23
- Accepted by EDGAR
- 2026-10-23 16:06 ET
- Event date
- 2026-10-21
- Accession no.
- 0001517022-26-000075
- Original filing
- SEC EDGAR filing index
Items reported
- Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The company received notice from its exchange that it does not satisfy a continued listing rule (for example a minimum bid price or filing requirement), or it decided to delist or transfer its listing.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | akba-20261021.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.